Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
复制标题
DOI:
10.1161/jaha.118.011427
复制
发表时间:
2019-06-18
影响因子:
5.4
通讯作者:
Gellad, Walid F.
中科院分区:
文献类型:
--
作者:
Hernandez, Inmaculada;He, Meiqi;Gellad, Walid F.
Background-Only 50% of atrial fibrillation (AF) patients recommended for oral anticoagulation (OAC) use these medications, and less than half of them adhere to OAC. In a cohort of Medicare beneficiaries newly diagnosed with AF, we identified groups of patients with similar trajectories of OAC use and adherence, and evaluated patient characteristics affecting group membership.Methods and Results-We selected continuously enrolled Medicare Part D beneficiaries with first AF diagnosis in 2014 to 2015 (n=34 898). We calculated the proportion of days covered with OAC over the first 12 months after diagnosis and identified OAC adherence trajectories using group-based trajectory models. We constructed multinomial logistic regression models to evaluate how demographics, system-level factors, and clinical characteristics were associated with group membership. We identified 4 trajectories of OAC adherence: patients who never used OAC (43.8%), late OAC initiators (7.6%), early OAC discontinuers (8.9%), and continuously adherent patients (40.1%). Predictors such as sex, black race, residence in the South, or HAS-BLED score were associated with not only OAC use, but also the timing of initiation and the likelihood of discontinuation. For example, HAS-BLED score >= 4 was associated with a higher likelihood of not using OAC (odds ratio 1.35; 95% CI, 1.14-1.62), of late initiation (1.55; 95% CI, 1.11-2.05), and of early discontinuation (odds ratio 1.35; 95% CI, 1.01-1.84).Conclusions-We identified 4 distinct trajectories of OAC adherence after first AF diagnosis, with